Cargando…

Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19

BACKGROUND: Persistent cognitive symptoms have been reported following COVID-19 hospitalization. We investigated the relationship between demographics, social determinants of health (SDOH) and cognitive outcomes 6-months after hospitalization for COVID-19. METHODS: We analyzed 6-month follow-up data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdes, Eduard, Fuchs, Benjamin, Morrison, Chris, Charvet, Leigh, Lewis, Ariane, Thawani, Sujata, Balcer, Laura, Galetta, Steven L., Wisniewski, Thomas, Frontera, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739793/ https://www.ncbi.nlm.nih.gov/pubmed/35031121 http://dx.doi.org/10.1016/j.jns.2022.120146

Ejemplares similares

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review
por: Lewis, Ariane, et al.
Publicado: (2021)

Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States
por: Frontera, Jennifer A., et al.
Publicado: (2021)

Cerebrospinal fluid in COVID-19: A systematic review of the literature
por: Lewis, Ariane, et al.
Publicado: (2021)

Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature
por: Carroll, Elizabeth, et al.
Publicado: (2021)

Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study
por: frontera, Jennifer A., et al.
Publicado: (2020)

Special considerations in the assessment of catastrophic brain injury and determination of brain death in patients with SARS-CoV-2
por: Valdes, Eduard, et al.
Publicado: (2020)

Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19
por: Frontera, Jennifer A., et al.
Publicado: (2021)

The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York City
por: Minen, Mia T, et al.
Publicado: (2022)

The Neurological Complications of Nutritional Deficiency following Bariatric Surgery
por: Becker, Danielle A., et al.
Publicado: (2012)

Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19
por: Gurin, Lindsey, et al.
Publicado: (2021)

King-Devick Test Performance and Cognitive Dysfunction after Concussion: A Pilot Eye Movement Study
por: Gold, Doria M., et al.
Publicado: (2021)

The King-Devick test of rapid number naming for concussion detection: meta-analysis and systematic review of the literature
por: Galetta, Kristin M, et al.
Publicado: (2015)

Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
por: Petrillo, Jennifer, et al.
Publicado: (2019)

The importance of race and other social determinants of health for understanding cognitive health inequality found in Valdes et al.'s “Demographic and social determinants of cognitive dysfunction following hospitalization of COVID-19”
por: Farina, Mateo P.
Publicado: (2022)

Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life
por: Chahin, Salim, et al.
Publicado: (2015)

The psychosocial implications of COVID-19 for a neurology program in a pandemic epicenter
por: Croll, Leah, et al.
Publicado: (2020)

Apparent lack of association of COVID-19 vaccination with Herpes Zoster
por: Patil, Sachi A., et al.
Publicado: (2022)

Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study
por: Perumal, Jai, et al.
Publicado: (2022)

Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
por: Perumal, Jai, et al.
Publicado: (2023)

Post-traumatic headache: the use of the sport concussion assessment tool (SCAT-3) as a predictor of post-concussion recovery
por: Begasse de Dhaem, Olivia, et al.
Publicado: (2017)

Trends in concussion mechanism of injury during the COVID-19 pandemic
por: Schaffer, Olivia, et al.
Publicado: (2023)

A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
por: Frontera, Jennifer A., et al.
Publicado: (2021)

Prevalence, Cognitive and Socio-Demographic Determinants of Prostate Cancer Screening
por: Mirzaei-Alavijeh, Mehdi, et al.
Publicado: (2018)

Alemtuzumab improves contrast sensitivity in patients with relapsing–remitting multiple sclerosis
por: Graves, Jennifer, et al.
Publicado: (2013)

Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19
por: Agarwal, Shashank, et al.
Publicado: (2021)

Acute optic neuritis: Unmet clinical needs and model for new therapies
por: Galetta, Steven L., et al.
Publicado: (2015)

Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis
por: Fernandez-Carbonell, Cristina, et al.
Publicado: (2021)

Editorial: Neurological and Neuroscientific Evidence in Aged COVID-19 Patients
por: Frontera, Jennifer A., et al.
Publicado: (2021)

Cognitive Dysfunction and its Determinants in Patients with Neurocysticercosis
por: Varghese, Vinod, et al.
Publicado: (2016)

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE
por: Perumal, Jai, et al.
Publicado: (2019)

Precision Concussion Management: Approaches to Quantifying Head Injury Severity and Recovery
por: de Souza, Daniel N., et al.
Publicado: (2023)

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis
por: Perumal, Jai, et al.
Publicado: (2023)

Postnatal depression in Southern Brazil: prevalence and its demographic and socioeconomic determinants
por: Tannous, Leila, et al.
Publicado: (2008)

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment
por: Vintimilla, Raul, et al.
Publicado: (2020)

The Making and Breaking of Social Ties During the Pandemic. Socio-Economic Position, Demographic Characteristics, and Changes in Social Networks
por: Bertogg, Ariane, et al.
Publicado: (2022)

Epigenetic determinants of space radiation-induced cognitive dysfunction
por: Acharya, Munjal M., et al.
Publicado: (2017)

Correspondence regarding: Post-traumatic headache: the use of the sport concussion assessment tool (SCAT-3) as a predictor of post-concussion recovery
por: Khazaei, Salman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ncofnct5c9l4drmciu9ein25o